Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Millions of Americans struggle with weight management, and semaglutide—the active ingredient in Wegovy—has shown remarkable clinical results, with patients losing up to 22% of body weight in pivotal trials. Understanding who qualifies for this therapy and what alternatives exist can help you take the next step toward sustainable weight loss with proper medical oversight.
Standard Wegovy Eligibility Criteria
Wegovy approval by the FDA established clear baseline requirements for candidacy. Adults must have a body mass index (BMI) of 30 kg/m² or greater, or a BMI of 27 or higher combined with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or heart disease. These thresholds reflect clinical evidence that semaglutide benefits outweigh risks for individuals meeting these profiles.
A licensed healthcare provider must evaluate your medical history, current medications, and family history before initiating therapy. This assessment ensures semaglutide is safe for you and that no contraindications exist—such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. The qualification process is straightforward but medically necessary.
Why Insurance Coverage Limits Access to Semaglutide
Wegovy prescriptions through traditional insurance often face significant barriers, including prior authorization requirements, stepped therapy protocols, and formulary restrictions. Many plans require documented weight loss attempts or specific BMI thresholds before approving coverage, delaying treatment for months. These gatekeeping mechanisms can mean the difference between starting therapy now and waiting indefinitely.
PlexusDx eliminates these delays by offering medically supervised semaglutide injections without requiring insurance approval. Patients pay a flat monthly rate starting at $149 for compounded semaglutide from licensed 503A pharmacies, making treatment accessible regardless of insurance status. This direct-access model ensures your qualification is based solely on clinical need and medical safety, not insurance company policies.
How PlexusDx Compounded Semaglutide Differs from Branded Wegovy
Compounded semaglutide and branded Wegovy contain the same active pharmaceutical ingredient, but compounded versions are prepared by licensed 503A compounding pharmacies under stricter oversight than manufacturers of branded drugs. Both forms undergo identical medical qualification processes—BMI assessment, medication review, and provider evaluation. The key difference lies in accessibility and cost, not efficacy or safety standards.
PlexusDx sources all medications from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality and potency verification. Your dose may need to go up as your body adjusts and your weight loss progresses. Your price won't—PlexusDx maintains flat monthly pricing at $149 regardless of dose level, making long-term therapy predictable and affordable.
Genetic Testing to Personalize Your Semaglutide Response
Not everyone responds identically to semaglutide therapy, and genetic variation significantly influences treatment outcomes. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants in the GLP1R gene (rs6923761), GIPR pathway (rs1800437), FTO (rs9939609), and MC4R (rs17782313) genes—mapping 14 metabolic pathways and 150+ personalized insights about your peptide response. This test costs $99 as an add-on after your first month of treatment.
Understanding your genetic profile helps your PlexusDx provider optimize your treatment from the start. Some individuals achieve faster weight loss and better appetite suppression with semaglutide alone, while others benefit from dual-compound therapies like GLP-Squared. Genetic insights remove guesswork, ensuring your medication and dose align with your unique biology rather than trial-and-error adjustments.
Getting Started with PlexusDx Semaglutide Treatment
Beginning semaglutide therapy through PlexusDx requires a brief medical consultation with a licensed provider to confirm your eligibility and establish a baseline health profile. You'll discuss your weight history, current medications, medical conditions, and weight loss goals. The provider will confirm that semaglutide is appropriate and safe for you, then authorize your first shipment from a licensed compounding pharmacy.
PlexusDx serves all 50 states without insurance requirements or membership fees, and all medications are HSA/FSA eligible. Your first month of compounded semaglutide injection starts at $149, with ongoing access to provider support and dose adjustments as needed. If genetic testing interests you, add the Precision Peptide Genetic Test at $99 in month two to unlock personalized pathway insights and optimize your results.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need to meet specific BMI requirements to qualify for PlexusDx semaglutide?
PlexusDx follows evidence-based medical guidelines: adults with a BMI of 30 or higher, or 27+ with weight-related health conditions like diabetes or hypertension, typically qualify. Your PlexusDx provider will review your full medical history during your consultation to confirm eligibility and ensure semaglutide is safe and appropriate for you.
What clinical evidence supports semaglutide for weight loss?
Pivotal clinical trials showed semaglutide users lost up to 22% of body weight over 68 weeks, compared to 2.6% in the placebo group—a fivefold improvement. These results formed the basis for FDA approval of Wegovy and demonstrate semaglutide's effectiveness when combined with diet and lifestyle modification.
How much does PlexusDx semaglutide cost compared to Wegovy?
PlexusDx compounded semaglutide injection starts at $149 per month with no insurance needed, no membership fee, and no hidden increases as your dose adjusts. Wegovy through insurance often requires prior authorization and may carry copays ranging from $200 to $500 monthly. PlexusDx pricing is transparent and flat regardless of dose level.
Are compounded medications from PlexusDx as safe as branded Wegovy?
Yes. PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which operate under strict FDA oversight and quality standards. Compounded semaglutide contains the same active ingredient as branded Wegovy and undergoes the same medical qualification and monitoring processes.
How can the Precision Peptide Genetic Test improve my semaglutide results?
PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to map 150+ personalized insights about your peptide pathways and metabolic response. These findings help your provider predict your semaglutide effectiveness and whether alternative therapies like oral semaglutide or dual-compound GLP-Squared might optimize your weight loss.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Your Plate: What Should I Not Eat on Ozempic for a Smoother Journey?
How to Keep Weight Off After Ozempic: A Guide to Sustainable Weight Management